We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 20

Implications of Distributor Misconduct for Global Health Care and Life Sciences Companies
  • Ropes & Gray LLP
  • USA, Global
  • August 2 2018

Health care and life sciences companies with operations in the United States and abroad face increased liability arising from their common reliance on


Implications of the UK’s Brexit Referendum
  • Ropes & Gray LLP
  • USA, United Kingdom, OECD, European Union, Global
  • September 1 2016

Potential implications on the use of passporting for asset management firms in a post-Brexit world Following the “Leave” result of the United


Anti-Corruption Laws and Other International Risks - What it Means for the Real Estate Industry and How to Protect against Risks
  • Ropes & Gray LLP
  • USA, United Kingdom, Global
  • August 11 2016

Bribery, money laundering, and sanctions are key international risk areas for any global business, particularly those investing or operating in


Edward Baer
  • Ropes & Gray LLP

David C. Djaha
  • Ropes & Gray LLP

Patrick J. Reinikainen
  • Ropes & Gray LLP

Elizabeth J. Reza
  • Ropes & Gray LLP

Kevin J. Angle
  • Ropes & Gray LLP

Ryan Rohlfsen
  • Ropes & Gray LLP

Joanna Torode
  • Ropes & Gray LLP